JIR
CCRN icon

James Investment Research’s Cross Country Healthcare CCRN Stock Holding History

James Investment Research’s Portfolio CCRN Stock Details CCRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,166
Closed -$48K – 320
2023
Q1 		$48K Buy
+2,166
New +$56.7K 0.01% 367

Other funds holding CCRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
SCM
Simcoe Capital Management New York $576M AUM 36.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

James Investment Research's CCRN Position: Q2 2023 in Review

James Investment Research sold out of Cross Country Healthcare (CCRN) in Q2 2023, closing a stake of 2,166 shares — an estimated $48K sold.

James Investment Research first reported a position in CCRN in Q1 2023 and held it in 1 quarter. The position peaked at $48K in Q1 2023. 194 funds tracked by Wall St. Rank hold CCRN as of Q2 2023.

  • James Investment Research reported no remaining Cross Country Healthcare position as of Q2 2023 after selling out during the quarter.
  • James Investment Research sold 2,166 Cross Country Healthcare shares in Q2 2023, an estimated $48K.
  • James Investment Research first reported a position in Cross Country Healthcare in Q1 2023 and held it in 1 quarter.
  • James Investment Research's Cross Country Healthcare position peaked at $48K in Q1 2023.
  • 194 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q2 2023.

Based on James Investment Research's 13F filing for Q2 2023, filed 7 Aug 2023.